- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Dornier names new president
Dornier Medical Systems of Kennesaw, GA, has a new management team in place. COO James Haisler has added the title of president to his duties, replacing Karl Jonietz, who has left Dornier to pursue other opportunities.Other new members of the DMSI team
Dornier Medical Systems of Kennesaw, GA, has a new management team in place. COO James Haisler has added the title of president to his duties, replacing Karl Jonietz, who has left Dornier to pursue other opportunities.
Other new members of the DMSI team include Manfred Drax, vice president of finance and administration; John McCauley, director of marketing; Tom Gibson, director of national service; and Bryan Smith, director of lithotripsy.
In other news, the company's Dornier Surgical Products subsidiary is conducting pilot studies on its Image Analysis System (IAS), which is designed to improve the treatment and detection of prostate disease. IAS allows physicians to see the extent of tissue destruction beneath the surface using existing ultrasound systems and Dornier's analysis console. The technique holds promise for identifying cancer within the prostate and in guiding the administration of transrectal biopsy, according to the company.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
